Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2016 |
Pennsylvania |
Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells |
Children’s Hospital of Pittsburgh / Erica Braverman, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Wei Tong, PhD |
Innovation Grants |
2019 |
Pennsylvania |
Children's Hospital of Pittsburgh Phase 1-2 Infrastructure Support Grant
|
University of Pittsburgh / A. Kim Ritchey, MD |
Phase I/II Infrastructure Grants |
2008 |
Pennsylvania |
Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Sarah Tasian |
Young Investigator Grants |
2012 |
Pennsylvania |
Molecular Annotation for Treatment of Childhood Cancers Trial: Neuroblastoma (MATCH-NB) |
Children’s Hospital of Philadelphia / Yael Mosse, M.D. |
Bio-Therapeutic Impact Award |
2015 |
Pennsylvania |
Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL |
University of Pennsylvania / Christian Hurtz, PhD |
Young Investigator Grants |
2018 |
Pennsylvania |
Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting |
Children’s Hospital of Philadelphia / Kristopher Bosse, MD |
'A' Award Grants |
2022 |
Pennsylvania |
Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant |
University of Pittsburgh / A. Kim Ritchey |
Phase I/II Infrastructure Grants |
2011 |
Pennsylvania |
Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias |
Children’s Hospital of Philadelphia / Alix Seif, MD |
Epidemiology Grants |
2016 |
Pennsylvania |